Form 8-K - Current report:
SEC Accession No. 0001213900-20-015571
Filing Date
2020-06-23
Accepted
2020-06-23 16:05:56
Documents
12
Period of Report
2020-06-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea123320-8k_nektartherap.htm   iXBRL 8-K 47679
  Complete submission text file 0001213900-20-015571.txt   221623

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE nktr-20200617.xsd EX-101.SCH 3170
3 XBRL LABEL FILE nktr-20200617_lab.xml EX-101.LAB 34581
4 XBRL PRESENTATION FILE nktr-20200617_pre.xml EX-101.PRE 22696
10 EXTRACTED XBRL INSTANCE DOCUMENT ea123320-8k_nektartherap_htm.xml XML 3501
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 20981970
SIC: 2834 Pharmaceutical Preparations